• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Hemophagocytic Lymphohistiocytosis Following COVID-19 Infection

tetano

Editor, Senior Moderator
Cureus


. 2023 Jan 28;15(1):e34307.
doi: 10.7759/cureus.34307. eCollection 2023 Jan.
Hemophagocytic Lymphohistiocytosis Following COVID-19 Infection


Guarina Molina[SUP] 1 [/SUP], Rafael Contreras[SUP] 1 [/SUP], Kyle Coombes[SUP] 2 [/SUP], Thilini Walgamage[SUP] 1 [/SUP], Maria A Perozo[SUP] 1 [/SUP], Martha T DesBiens[SUP] 3 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with multiple inflammatory symptoms involving several organ systems, including hematologic manifestations. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome caused by excessive inflammation in the absence of immune regulation. We present the case of a patient with HLH secondary to dysregulated inflammatory response following COVID-19; we also describe the diagnostic and management challenges associated with the condition.

Keywords: covid 19; disseminated intravascular coagulation (dic); hemophagocytic lymphohistiocytosis (hlh); inflammatory mediators; pancytopenia; soluble interleukin receptors.
 
Back
Top Bottom